New Rosacea Treatments

One of the hottest areas of interest online for rosacea sufferers is new rosacea treatments. From the industry heavyweights like Galderma, Allergan, Bayer, Valeant and Stiefel to little companies like MooGoo there is a lot of interest in the up and coming rosacea treatments. See below for the latest information about what is just over the horizon.

Recent Rosacea Blog Posts

New and Emerging Rosacea Topicals

One of the things I like to achieve with Rosacea News is to surface new and emerging rosacea topicals – giving a view of the sorts of topicals that are around the corner and might offer innovative treatments. One might sometimes feel that there isn’t much happening on behalf of us rosacea sufferers, but there […]

Continue Reading

3% Praziquantel (PZQ) for the redness of rosacea

This recent paper from International Journal of Dermatology introduces us to the compound known as Praziquantel. We learn that this active can be formulated into a 3% topical which shows antimicrobial activity. Praziquantel, also known as Biltricide, has been used orally for the treatment of parasitic worms. This trial is the first reported use of Praziquantel topcially. The study […]

Continue Reading

Promius files NDA for modified release tetracycline Zenavod (DFD-09)

Promius Pha rma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for […]

Continue Reading

How does Soolantra (topical ivermectin) work?

Ahead of the expected approval and launch of Galderma’s Ivermectin 1% Cream is this abstract further highlighting the credentials of topical ivermectin. How does Ivermectin exhibit superior papule and pustule clearing abilities ? Well this paper tells us that topical ivermectin is effective because of its antimicrobial, antiparasitic, antibacterial, and anti-inflammatory activities. Galderma is expected […]

Continue Reading

Actavis to trial Mirvaso competitor

An interesting development in rosacea clinical trials is the emergence of a new company called Actavis. Actavis have listed a large trial where they plan to test their Brimonidine Gel against Galderma’s recently FDA approved Brimonidine-based Mirvaso Gel. The large Phase 3 trial will compare the response after 7 days. Up to 462 patients in […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.